Transgenic Group (TSE:2342) Retained Earnings: 円850 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2342 Transgenic Group Inc TSE:2342
64 GF Score
Price 円257.00
GF Value 円256.01
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Retained Earnings?

Transgenic Group TSE:2342 -0.39% 64 Retained Earnings is 円850 Mil as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 64/100 and a GF Value™ of 円256.01 (Fairly Valued). The stock has 4 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Transgenic Group's retained earnings for the quarter that ended in Mar. 2026 was 円850 Mil.

Transgenic Group's quarterly retained earnings declined from Sep. 2025 (円957 Mil) to Dec. 2025 (円956 Mil) and declined from Dec. 2025 (円956 Mil) to Mar. 2026 (円850 Mil).

Transgenic Group's annual retained earnings declined from Mar. 2024 (円2,067 Mil) to Mar. 2025 (円928 Mil) and declined from Mar. 2025 (円928 Mil) to Mar. 2026 (円850 Mil).


Transgenic Group  (TSE:2342) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Transgenic Group Retained Earnings Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Retained Earnings Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,657.87 2,147.30 2,067.10 927.67 850.41

Transgenic Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 954.63 957.22 955.69 850.41 986.44
TSE:2342
64GF Score
Transgenic Group Inc TSE:2342
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of 円850 Mil mean?
Transgenic Group (TSE:2342) has a Retained Earnings of 円850 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Transgenic Group and its competitors.
Is Transgenic Group's Retained Earnings too high?
Transgenic Group's current Retained Earnings is 円850 Mil. Overall, Transgenic Group has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Retained Earnings compare to VRTX and REGN?
Transgenic Group's Retained Earnings of 円850 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Transgenic Group and its competitors. Transgenic Group's current Retained Earnings is 円850 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Fairly Valued. The stock's GF Value™ is 円256.01, compared to a current price of 円257.00 — trading 0.4% above its estimated fair value. The current Retained Earnings is 円850 Mil. Transgenic Group's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Retained Earnings is 円850 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be overvalued. The current stock price of 円257.00 is trading 0.4% above its estimated GF Value™ of 円256.01. GuruFocus considers Transgenic Group to be Fairly Valued.

Key valuation signals for TSE:2342:

  • Retained Earnings: 円850 Mil
  • GF Value™: 円256.01 vs. price of 円257.00 (0.4% above fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
64GF Score

Get the complete analysis for TSE:2342

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円257.00
Price
円256.01
GF Value